Introduction Locally advanced rectal cancer (LARC) is a stage II or stage III disease that has experienced a paradigm shift in management over the past few decades (1). Advances in surgical technique, namely total mesorectal excision (TME) and the development of combined modality therapy, have led to markedly improved disease-related outcomes (1).